Covestor LTD Moderna, Inc. Transaction History

Covestor LTD

$160 Million
Q3 2024

A detailed history of Covestor LTD transactions in Moderna, Inc. stock. As of the latest transaction made, Covestor LTD holds 158 shares of MRNA stock, worth $6,043. This represents 0.01% of its overall portfolio holdings.

Number of Shares

158

Previous 156 1.28%

Holding current value

$6,043

Previous $19,000 42.11%

% of portfolio

0.01%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$63.64 - $125.14 $127 - $250	2 Added 1.28%	158 $11,000
Q2 2024 Aug 09, 2024	SELL	$101.21 - $166.61 $26,010 - $42,818	-257 Reduced 62.23%	156 $19,000
Q1 2024 May 10, 2024	SELL	$85.37 - $115.44 $23,220 - $31,399	-272 Reduced 39.71%	413 $44,000
Q4 2023 Feb 09, 2024	SELL	$69.51 - $104.43 $43,791 - $65,790	-630 Reduced 47.91%	685 $68,000
Q3 2023 Nov 13, 2023	BUY	$96.41 - $126.61 $111,064 - $145,854	1,152 Added 706.75%	1,315 $136,000
Q2 2023 Aug 11, 2023	BUY	$118.5 - $160.53 $3,081 - $4,173	26 Added 18.98%	163 $20,000
Q1 2023 May 15, 2023	SELL	$135.66 - $197.02 $1,627 - $2,364	-12 Reduced 8.05%	137 $21,000
Q4 2022 Feb 13, 2023	SELL	$118.38 - $210.04 $16,218 - $28,775	-137 Reduced 47.9%	149 $26,000
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $114,645 - $188,548	-971 Reduced 77.25%	286 $34,000
Q2 2022 Aug 10, 2022	BUY	$117.13 - $176.59 $6,793 - $10,242	58 Added 4.84%	1,257 $179,000
Q1 2022 May 13, 2022	BUY	$126.46 - $235.05 $105,720 - $196,501	836 Added 230.3%	1,199 $207,000
Q4 2021 Feb 10, 2022	BUY	$225.82 - $368.51 $81,972 - $133,769	363 New	363 $92,000

Others Institutions Holding MRNA

# of Institutions

952

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.

Account